Novel analogs of PSNCBAM-1 as allosteric modulators of cannabinoid CB1 receptor

被引:14
|
作者
Bertini, Simone [1 ]
Chicca, Andrea [2 ]
Gado, Francesca [1 ]
Arena, Chiara [1 ]
Nieri, Daniela [2 ]
Digiacomo, Maria [1 ]
Saccomanni, Giuseppe [1 ]
Zhao, Pingwei [3 ]
Abood, Mary E. [3 ]
Macchia, Marco [1 ]
Gertsch, Jurg [2 ]
Manera, Clementina [1 ]
机构
[1] Univ Pisa, Dept Pharm, I-56126 Pisa, Italy
[2] Univ Bern, NCCR TransCure, Inst Biochem & Mol Med, Buhlstr 28, CH-3012 Bern, Switzerland
[3] Temple Univ, Lewis Katz Sch Med, Ctr Subst Abuse Res, Philadelphia, PA 19140 USA
关键词
Allosteric modulator; CB1; receptor; Endocannabinoid system; MAPK/ERK signaling pathway; Serum response element; ENDOCANNABINOID SYSTEM; HUMAN HEALTH; PHARMACOLOGY; STRATEGIES; AGONISTS; PAIN;
D O I
10.1016/j.bmc.2017.10.015
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this work, we explored the molecular framework of the known CB1R allosteric modulator PSNCBAM-1 with the aim to generate new bioactive analogs and to deepen the structure-activity relationships of this type of compounds. In particular, the introduction of a NH group between the pyridine ring and the phenyl nucleus generated the amino-phenyl-urea derivative SN15b that behaved as a positive allosteric modulator (PAM), increasing the CB1R binding affinity of the orthosteric ligand CP55,940. The functional activity was evaluated using serum response element (SRE) assay, which assesses the CB1R-dependent activation of the MAPK/ERK signaling pathway. SN15b and the biphenyl-urea analog SC4a significantly inhibited the response produced by CP55,940 in the low mu M range, thus behaving as negative allosteric modulators (NAMs). The new derivatives presented here provide further insights about the modulation of CB1R binding and functional activity by allosteric ligands. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6427 / 6434
页数:8
相关论文
共 50 条
  • [41] Negative allosteric modulators of cannabinoid receptor 1: Ternary complexes including CB1, orthosteric CP55940 and allosteric ORG27569
    Aderibigbe, AyoOluwa O.
    Pandey, Pankaj
    Doerksen, Robert J.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (13): : 5729 - 5747
  • [42] Novel sterically hindered cannabinoid CB1 receptor ligands
    Urbani, Paolo
    Cascio, Maria Grazia
    Ramunno, Anna
    Bisogno, Tiziana
    Saturnino, Carmela
    Di Marzo, Vincenzo
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (15) : 7510 - 7515
  • [43] Highly selective CB1 cannabinoid receptor ligands and novel CB1/VR1 vanilloid receptor "hybrid" ligands
    Di Marzo, V
    Bisogno, T
    De Petrocellis, L
    Brandi, I
    Jefferson, RG
    Winckler, RL
    Davis, JB
    Dasse, O
    Mahadevan, A
    Razdan, RK
    Martin, BR
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 281 (02) : 444 - 451
  • [44] Internalization and recycling of the CB1 cannabinoid receptor
    Hsieh, C
    Brown, S
    Derleth, C
    Mackie, K
    JOURNAL OF NEUROCHEMISTRY, 1999, 73 (02) : 493 - 501
  • [45] Voltage dependence of the cannabinoid CB1 receptor
    Goldberger, Esty
    Tauber, Merav
    Ben-Chaim, Yair
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [46] ALLOSTERIC MODULATION AND BIASED SIGNALLING AT CB1 CANNABINOID RECEPTORS
    Khajehali, E.
    Malone, D.
    Leach, K.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 177 - 177
  • [47] Signal transduction of the CB1 cannabinoid receptor
    Turu, Gabor
    Hunyady, Laszlo
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2010, 44 (02) : 75 - 85
  • [48] CB1 Receptor Allosteric Modulators Display Both Agonist and Signaling Pathway Specificity
    Baillie, Gemma L.
    Horswill, James G.
    Anavi-Goffer, Sharon
    Reggio, Patricia H.
    Bolognini, Daniele
    Abood, Mary E.
    McAllister, Sean
    Strange, Phillip G.
    Stephens, Gary J.
    Pertwee, Roger G.
    Ross, Ruth A.
    MOLECULAR PHARMACOLOGY, 2013, 83 (02) : 322 - 338
  • [49] CB1 allosteric modulators and their therapeutic potential in CNS disorders
    Mielnik, Catharine A.
    Lam, Vincent M.
    Ross, Ruth A.
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2021, 106
  • [50] A kinetic model for positive allosteric modulator (PAM)-antagonists for the type 1 cannabinoid (CB1) receptor
    Yang, Liang
    Zhu, Xiao
    Finlay, David B.
    Green, Hayley
    Glass, Michelle
    Duffull, Stephen B.
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 (20) : 2661 - 2676